Ignite Creation Date:
2024-05-06 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 12:45 PM
Study NCT ID:
NCT03519412
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-09-28
First Post:
2018-04-26
Brief Title:
Pembrolizumab in MMR-Proficient Metastatic Colorectal Cancer Pharmacologically Primed to Trigger Hypermutation Status
Sponsor:
IFOM ETS - The AIRC Institute of Molecular Oncology
Organization:
IFOM ETS - The AIRC Institute of Molecular Oncology
Organization Data
Organization:
IFOM ETS - The AIRC Institute of Molecular Oncology
Class:
OTHER
Study ID:
IFOM-CPT0022018PO001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
IFOM ETS - The AIRC Institute of Molecular Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None